Alnuctamab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Alnuctamab, covering 2024-05-31 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Alnuctamab for Refractory SLE (LATTE Study) [Phase 1]